Walmart Expands Employee Healthcare: Free GLP-1s, Insulin, and More

As healthcare costs continue to climb across the United States, major employers are facing a difficult choice: either increase premiums or scale back benefits. Walmart, the nation's largest private employer, is choosing a different path. The retail giant has announced a significant expansion of its employee healthcare benefits, aiming to attract and retain talent in a highly competitive labor market.

Starting in 2027, Walmart will cover more than 250 prescriptions, including essential medications like insulin, inhalers, and diabetes treatments, at no cost to its employees. This move comes as the company seeks to differentiate itself from competitors who are increasingly passing costs onto workers. The announcement was made just weeks before the annual open enrollment period for Walmart employees closes on November 6.

Key Highlights of the New Benefits

• Expanded Prescription Coverage: Walmart will now cover over 250 prescriptions at no cost, including insulin and inhalers. This is a major step forward in making essential medications accessible to employees.
• Free GLP-1s for Diabetes: Employees with Type 2 diabetes will have access to Novo Nordisk's Ozempic and Eli Lilly's Mounjaro without charge, provided they meet prior authorization requirements. However, these treatments are not covered for weight loss purposes.
• Minimized Premium Increases: While the company is raising premiums for its starting plan by $1.50 per pay period (to $39.80), this is a smaller increase compared to the previous year. Walmart is also minimizing premium hikes for other plans.
• Specialist Care Expansion: Walmart is expanding its existing benefit that pays for cancer specialist visits at the Mayo Clinic or the Cleveland Clinic. Starting next year, employees can use this benefit to seek second opinions for rare conditions like ALS, multiple sclerosis, and Parkinson's.
• Extended Parental Leave: New parents will be eligible for up to 12 weeks of neonatal intensive care unit (NICU) leave, which can be added on top of regular parental and maternity leave.

In-Depth Analysis

Walmart's decision to expand benefits comes at a critical time. The company employs roughly 2.1 million associates worldwide, with about 1.6 million based in the U.S. For years, Walmart has faced criticism for its wages and healthcare offerings. This latest move appears to be a strategic effort to rebuild its reputation and improve employee satisfaction.

The inclusion of GLP-1s like Ozempic and Mounjaro is particularly noteworthy. While these drugs are widely used for Type 2 diabetes, they have also gained popularity for weight loss. Walmart's decision to cover them for diabetes but not for weight loss aligns with the policies of many other large employers, who are wary of the high costs associated with obesity treatments. By focusing on diabetes care, Walmart is addressing a critical health need while managing its own healthcare expenses.

The expansion of specialist care, particularly at top-tier institutions like the Mayo Clinic and the Cleveland Clinic, is another smart move. This benefit not only provides employees with access to world-class care but also serves as a powerful recruitment tool. In an era where talent is scarce, offering such comprehensive benefits can be a decisive factor for job seekers.

Furthermore, the company's commitment to minimizing premium increases is a relief for employees. Inflation and rising drug prices have made healthcare a growing burden for many families. By keeping premium hikes relatively low, Walmart is demonstrating a commitment to its workforce's financial well-being.

Looking ahead, Walmart's approach sets a precedent for other large employers. As the cost of healthcare continues to rise, companies that prioritize employee well-being over short-term savings may find themselves with a more loyal and productive workforce. Walmart's strategy suggests that investing in employees is not just a moral imperative but also a smart business decision.

Frequently Asked Questions

Will all GLP-1 medications be covered?

No, only GLP-1s specifically prescribed for Type 2 diabetes will be covered at no cost. Treatments for weight loss purposes will not be included in this benefit.

How much will the new premiums be?

The starting plan premium will increase by $1.50 per pay period, bringing the total to $39.80. This is a smaller increase compared to the previous year.

Can I use the specialist benefit for any condition?

Currently, the benefit is primarily for cancer care. Starting next year, employees will be able to use it for second opinions on rare conditions like ALS, multiple sclerosis, and Parkinson's.

Source: https://www.cnbc.com/2026/10/13/walmart-glp-1s-inhalers-insulin-employee-benefits.html